What does Trump’s action on the FDA and health care mean for investors? Who will benefit with thispending action against Big Pharma and what companies should see a positive jump from this action? Thanks Travis.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
To be honest, I don’t quite get Trump’s decisions. However, whatever they are, there is one thing I am extremely sure of. That is, biology is still the most promising science in the 21st century. Thus, it’s unwise to predict that the medical industry is going to degenerate. On the contrary, it will develop very fast. Companies specializing in domain library production (https://www.creative-biolabs.com/single-domain-antibody-library-service.html) will benefit, believe it or not.